An Association Between Selective Serotonin Reuptake Inhibitor Use and Serious Upper Gastrointestinal Bleeding
Authors:
- 1 December 2009
- journal article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 7 (12) , 1314-1321
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Gastro‐intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new lookBritish Journal of Clinical Pharmacology, 2008
- Risk of Upper Gastrointestinal Bleeding and the Degree of Serotonin Reuptake Inhibition by AntidepressantsDrug Safety, 2008
- Are lifestyle changes achieved after participation in a screening programme for Type 2 diabetes? The ADDITION Study, DenmarkDiabetic Medicine, 2007
- Antiplatelet Properties of Escitalopram in Patients with the Metabolic Syndrome: A Dose-Ranging In Vitro StudyNeuropsychopharmacology, 2007
- Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control studyBMJ, 2006
- Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinationsGut, 2006
- Antidepressant drug use in Lombardy, Italy: a population-based studyJournal of Affective Disorders, 2004
- Eradication of Helicobacter pylori and use of antisecretory drugs: population based cohort studyBMJ, 2003
- Selective Serotonin Reuptake Inhibitors and the Risk of StrokeStroke, 2002
- Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleedingAlimentary Pharmacology & Therapeutics, 2002